Detalles de la búsqueda
1.
Real-world analysis of MET exon 14 mutations in non-small cell lung cancer: a retrospective study from two Swedish hospitals.
Acta Oncol
; 62(12): 1808-1814, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37897706
2.
Complications following novel therapies for non-small cell lung cancer.
J Intern Med
; 291(6): 732-754, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35032058
3.
Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature.
J Immunother Cancer
; 11(3)2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36878533
4.
Osimertinib-induced syndrome of inappropriate secretion of antidiuretic hormone in oncogene-addicted lung adenocarcinoma: A case report.
Lung Cancer
; 166: 132-134, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35276629
5.
Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy.
Cancers (Basel)
; 13(7)2021 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33805335
6.
Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitors.
Eur J Cancer
; 145: 245-254, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33419647
7.
Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' Setting.
Cancers (Basel)
; 12(12)2020 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33321730
Resultados
1 -
7
de 7
1
Próxima >
>>